Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
Submitted by
admin
on August 11, 2012 - 12:57pm
Source:
Pipeline Review
News Tags:
Lucentis
Genentech
Roche
diabetic macular edema
Headline:
FDA Approves Lucentis (Ranibizumab Injection) for Treatment of Diabetic Macular Edema (DME)
Do Not Allow Advertisers to Use My Personal information
